GTC projects cash and marketable securities at the end of 2007 totaling approximately $20 to $22 million assuming the completion of partnering transactions currently under discussion as well as anticipated revenues from existing external programs with Merrimack and PharmAthene.
Great news!! I hope this is thoroughly covered in the CC